These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19533761)

  • 1. Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications.
    Fleury MJ; Touzé A; Maurel MC; Moreau T; Coursaget P
    Protein Sci; 2009 Jul; 18(7):1425-38. PubMed ID: 19533761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.
    Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P
    J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.
    Fleury MJ; Touzé A; Alvarez E; Carpentier G; Clavel C; Vautherot JF; Coursaget P
    Arch Virol; 2006 Aug; 151(8):1511-23. PubMed ID: 16508703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
    Xia L; Xian Y; Wang D; Chen Y; Huang X; Bi X; Yu H; Fu Z; Liu X; Li S; An Z; Luo W; Zhao Q; Xia N
    Sci Rep; 2016 Jan; 6():19042. PubMed ID: 26750243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
    Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
    Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.
    Roth SD; Sapp M; Streeck RE; Selinka HC
    Virol J; 2006 Oct; 3():83. PubMed ID: 17014700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.
    Combita AL; Touzé A; Bousarghin L; Christensen ND; Coursaget P
    J Virol; 2002 Jul; 76(13):6480-6. PubMed ID: 12050360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.
    Bissett SL; Godi A; Fleury MJ; Touze A; Cocuzza C; Beddows S
    J Virol; 2015 Aug; 89(15):7748-57. PubMed ID: 25995264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope.
    Sadeyen JR; Tourne S; Shkreli M; Sizaret PY; Coursaget P
    Virology; 2003 Apr; 309(1):32-40. PubMed ID: 12726724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the mimotopes within the major capsid protein L1 of human papillomavirus types 18 and 45, using neutralizing monoclonal antibodies.
    Li N; Zhang G; Chen Y; Zhou J; Hui C; Li S; Liu H; Liu Y; Qi Y; Wang A
    Int J Biol Macromol; 2021 Mar; 174():587-595. PubMed ID: 33493568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.
    Bishop B; Dasgupta J; Klein M; Garcea RL; Christensen ND; Zhao R; Chen XS
    J Biol Chem; 2007 Oct; 282(43):31803-11. PubMed ID: 17804402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity pattern of 92 monoclonal antibodies with 15 human papillomavirus types.
    Rizk RZ; Christensen ND; Michael KM; Müller M; Sehr P; Waterboer T; Pawlita M
    J Gen Virol; 2008 Jan; 89(Pt 1):117-129. PubMed ID: 18089735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1.
    Carter JJ; Wipf GC; Benki SF; Christensen ND; Galloway DA
    J Virol; 2003 Nov; 77(21):11625-32. PubMed ID: 14557648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera.
    Carter JJ; Wipf GC; Madeleine MM; Schwartz SM; Koutsky LA; Galloway DA
    J Virol; 2006 May; 80(10):4664-72. PubMed ID: 16641259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
    Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
    Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
    J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The generation and characterisation of neutralising antibodies against the Theiler's murine encephalomyelitis virus (TMEV) GDVII capsid reveals the potential binding site of the host cell co-receptor, heparan sulfate.
    Upfold N; Ross C; Bishop ÖT; Luke GA; Knox C
    Virus Res; 2018 Jan; 244():153-163. PubMed ID: 29155139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that papillomavirus capsids exist in two distinct conformations.
    Selinka HC; Giroglou T; Nowak T; Christensen ND; Sapp M
    J Virol; 2003 Dec; 77(24):12961-7. PubMed ID: 14645552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.